SCP
SymBiosis Capital Partners Portfolio holdings
AUM
$109M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$109M
AUM Growth
–
Holding
11
Top Buys
| 1 | +$24.1M | |
| 2 | +$17.8M | |
| 3 | +$12.1M | |
| 4 |
Precigen
PGEN
|
+$11.6M |
| 5 |
Rani Therapeutics
RANI
|
+$9.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 83.78% |
| 2 | Technology | 12.09% |
| 3 | Consumer Staples | 4.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVMN
1
Evommune Inc
EVMN
$941M
| $21.9M | 20.03% |
+1,280,778
|
|
||
2
Verastem
VSTM
$439M
| $15.4M | 14.1% |
+2,000,000
|
|
||
3
AmpliTech
AMPG
$69M
| $13.2M | 12.09% |
+2,555,000
|
|
||
|
4
Precigen
PGEN
$1.36B
| $12.5M | 11.45% |
+3,000,000
|
|
||
|
IVA
5
Inventiva
IVA
$1.41B
| $12.1M | 11.04% |
+2,600,000
|
|
||
6
Nuvation Bio
NUVB
$1.91B
| $11.2M | 10.23% |
+1,250,000
|
|
||
|
7
Rani Therapeutics
RANI
$132M
| $8.51M | 7.77% |
+6,300,000
|
|
||
|
AARD
8
Aardvark Therapeutics
AARD
$270M
| $6.26M | 5.71% |
+476,595
|
|
||
9
Clene
CLNN
$58.4M
| $4.52M | 4.13% |
+770,495
|
|
||
|
GBIO
10
DELISTED
Generation Bio
GBIO
| $3.78M | 3.45% |
+665,000
|
|
||
11
Surrozen Inc Warrant
SRZNW
$61K
| $3K | ﹤0.01% |
+150,000
|
|